Hypomethylating agents (HMAs) effect on myelodysplastic/myeloproliferative neoplasm unclassifiable (MDS/MPN-U): single institution experience

Aref Al-Kali, Ahmed Kamel Abou Hussein, Mrinal Patnaik, Darci Zblewski, Naseema Gangat, Shahrukh Hashmi, Michelle Elliott, William Hogan, Mark Litzow

Research output: Contribution to journal › Letter › peer-review

7 Scopus citations

Fingerprint

Dive into the research topics of 'Hypomethylating agents (HMAs) effect on myelodysplastic/myeloproliferative neoplasm unclassifiable (MDS/MPN-U): single institution experience'. Together they form a unique fingerprint.